Last update :
05/12/2025
Antiviral   Cidofovir  
injection
Stability in solutions Stability of mixtures Factors which affect stability Compatibility Route of administration References pdf
   Chemical structure  

Tradename   Tradename     

Trade names are indicative and excipients composition can be different depending on the country and manufacturers

Cidofovir Finland, France, Germany, Great Britain, Spain
Sidovis Switzerland
Vistide Austria, Denmark, Greece, Japan, Luxembourg, Mexico, Netherlands, New Zealand, Poland, Portugal, Romania, United States of America
References   injection   References : Cidofovir  
Type Publication
1 Journal Yuan LC, Samuels GJ, Visor GC.
Stability of cidofovir in 0.9% sodium chloride and in 5% dextrose injection.
Am J Health-Syst Pharm 1996 ; 53: 1939-1943.
71 Journal Ennis RD, Dahl TC.
Stability of cidofovir in 0.9% sodium chloride injection for five days.
Am J Health-Syst Pharm 1997 ; 54: 2204-2206.
1989 Journal Hennere G, Havard L, Bonan B, Prognon P.
Stability of cidofovir in extemporaneously prepared syringes.
Am J Health-Syst Pharm 2005 ; 62: 506-509.
4970 Manufacturer CIDOFOVIR TILLOMED 75 mg/mL solution à diluer pour perfusion - Résumé des caractéristiques du produit.
TILLOMED PHARMA GMBH 2024

  Mentions Légales